Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common stock, $0.001 par value per share
-
Shares outstanding
-
12,986,368
-
Total 13F shares
-
1,913,224
-
Share change
-
+1,912,224
-
Total reported value
-
$24,390,000
-
Price per share
-
$12.75
-
Number of holders
-
28
-
Value change
-
+$24,377,028
-
Number of buys
-
27
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) as of Q1 2014
As of 31 Mar 2014,
EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,913,224 shares.
The largest 10 holders included
Cormorant Asset Management, LLC, DEERFIELD MANAGEMENT CO, Park West Asset Management LLC, WALL STREET ASSOCIATES, JPMORGAN CHASE & CO, JENNISON ASSOCIATES LLC, Allianz Asset Management AG, FARALLON CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, and BlackRock Institutional Trust Company, N.A..
This page lists
28
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.